Metropolis Healthcare Limited (METROPOLIS.NS)

INR 2128.15

(-0.16%)

EBITDA Summary of Metropolis Healthcare Limited

Metropolis Healthcare Limited's latest annual EBITDA in 2023 was 2.96 Billion INR , down -6.9% from previous year.
Metropolis Healthcare Limited's latest quarterly EBITDA in 2024 Q1 was 788.13 Million INR , down -1.51% from previous quarter.
Metropolis Healthcare Limited reported an annual EBITDA of 3.08 Billion INR in 2022, down -15.7% from previous year.
Metropolis Healthcare Limited reported an annual EBITDA of 3.81 Billion INR in 2021, up 20.98% from previous year.
Metropolis Healthcare Limited reported a quarterly EBITDA of 659.91 Million INR for 2023 Q1, down -7.72% from previous quarter.
Metropolis Healthcare Limited reported a quarterly EBITDA of 760.29 Million INR for 2023 Q2, up 15.21% from previous quarter.

Annual EBITDA Chart of Metropolis Healthcare Limited (2023 - 2013)

Historical Annual EBITDA of Metropolis Healthcare Limited (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	2.96 Billion INR	-6.9%
2022	3.08 Billion INR	-15.7%
2021	3.81 Billion INR	20.98%
2020	3.01 Billion INR	35.64%
2019	2.2 Billion INR	6.75%
2018	2.1 Billion INR	13.96%
2017	1.85 Billion INR	9.53%
2016	1.76 Billion INR	22.22%
2015	1.42 Billion INR	14.75%
2014	1.17 Billion INR	10.07%
2013	1.06 Billion INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	788.13 Million INR	-1.51%
2023 Q1	659.91 Million INR	-7.72%
2023 Q2	760.29 Million INR	15.21%
2023 Q3	671.52 Million INR	-11.68%
2023 Q4	799.79 Million INR	19.1%
2023 FY	- INR	-6.9%
2022 Q2	833.65 Million INR	16.54%
2022 FY	- INR	-15.7%
2022 Q4	715.12 Million INR	-7.26%
2022 Q3	771.12 Million INR	-7.5%
2022 Q1	715.3 Million INR	-10.76%
2021 FY	- INR	20.98%
2021 Q2	958.16 Million INR	-9.72%
2021 Q3	779.39 Million INR	-18.66%
2021 Q4	801.53 Million INR	2.84%
2021 Q1	1.06 Billion INR	8.29%
2020 Q1	152.62 Million INR	-58.2%
2020 Q2	939.45 Million INR	515.55%
2020 Q4	980.12 Million INR	8.44%
2020 Q3	903.85 Million INR	-3.79%
2020 FY	- INR	35.64%
2019 Q1	562.41 Million INR	-3.52%
2019 FY	- INR	6.75%
2019 Q4	365.08 Million INR	-44.48%
2019 Q3	657.53 Million INR	2.09%
2019 Q2	644.05 Million INR	14.52%
2018 Q4	582.92 Million INR	14.3%
2018 FY	- INR	13.96%
2018 Q3	509.98 Million INR	6.92%
2018 Q2	476.98 Million INR	3.33%
2018 Q1	461.59 Million INR	0.0%
2017 FY	- INR	9.53%
2016 FY	- INR	22.22%
2015 FY	- INR	14.75%
2014 FY	- INR	10.07%
2013 FY	- INR	0.0%

Peer EBITDA Comparison of Metropolis Healthcare Limited

Name	EBITDA	EBITDA Difference
Krsnaa Diagnostics Limited	1.61 Billion INR	-84.419%
Dr. Lal PathLabs Limited	6.78 Billion INR	56.205%
Thyrocare Technologies Limited	1.48 Billion INR	-100.494%
Vijaya Diagnostic Centre Limited	2.2 Billion INR	-34.447%
Vimta Labs Limited	878.1 Million INR	-238.221%